Literature DB >> 20844478

Cognitive control deficits in schizophrenia: mechanisms and meaning.

Tyler A Lesh1, Tara A Niendam, Michael J Minzenberg, Cameron S Carter.   

Abstract

Although schizophrenia is an illness that has been historically characterized by the presence of positive symptomatology, decades of research highlight the importance of cognitive deficits in this disorder. This review proposes that the theoretical model of cognitive control, which is based on contemporary cognitive neuroscience, provides a unifying theory for the cognitive and neural abnormalities underlying higher cognitive dysfunction in schizophrenia. To support this model, we outline converging evidence from multiple modalities (eg, structural and functional neuroimaging, pharmacological data, and animal models) and samples (eg, clinical high risk, genetic high risk, first episode, and chronic subjects) to emphasize how dysfunction in cognitive control mechanisms supported by the prefrontal cortex contribute to the pathophysiology of higher cognitive deficits in schizophrenia. Our model provides a theoretical link between cellular abnormalities (eg, reductions in dentritic spines, interneuronal dysfunction), functional disturbances in local circuit function (eg, gamma abnormalities), altered inter-regional cortical connectivity, a range of higher cognitive deficits, and symptom presentation (eg, disorganization) in the disorder. Finally, we discuss recent advances in the neuropharmacology of cognition and how they can inform a targeted approach to the development of effective therapies for this disabling aspect of schizophrenia.

Entities:  

Mesh:

Year:  2010        PMID: 20844478      PMCID: PMC3052853          DOI: 10.1038/npp.2010.156

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  340 in total

Review 1.  Opponent interactions between serotonin and dopamine.

Authors:  Nathaniel D Daw; Sham Kakade; Peter Dayan
Journal:  Neural Netw       Date:  2002 Jun-Jul

2.  Another view of therapy for cognition in schizophrenia.

Authors:  William T Carpenter; James M Gold
Journal:  Biol Psychiatry       Date:  2002-06-15       Impact factor: 13.382

Review 3.  The frontal lobes and the regulation of mental activity.

Authors:  Sharon L Thompson-Schill; Marina Bedny; Robert F Goldberg
Journal:  Curr Opin Neurobiol       Date:  2005-04       Impact factor: 6.627

Review 4.  Presynaptic modulation by endocannabinoids.

Authors:  David M Lovinger
Journal:  Handb Exp Pharmacol       Date:  2008

Review 5.  A neural substrate of prediction and reward.

Authors:  W Schultz; P Dayan; P R Montague
Journal:  Science       Date:  1997-03-14       Impact factor: 47.728

Review 6.  Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis.

Authors:  Jin-Bo Fan; Chang-Shun Zhang; Niu-Fan Gu; Xing-Wang Li; Wei-Wei Sun; Hong-Yan Wang; Guo-Yin Feng; David St Clair; Lin He
Journal:  Biol Psychiatry       Date:  2005-01-15       Impact factor: 13.382

Review 7.  Endophenotypes in the genetic analyses of mental disorders.

Authors:  Tyrone D Cannon; Matthew C Keller
Journal:  Annu Rev Clin Psychol       Date:  2006       Impact factor: 18.561

Review 8.  GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia.

Authors:  Guillermo Gonzalez-Burgos; David A Lewis
Journal:  Schizophr Bull       Date:  2008-06-26       Impact factor: 9.306

9.  A pen-and-paper human analogue of a monkey prefrontal cortex activation task: spatial working memory in patients with schizophrenia.

Authors:  R S Keefe; S E Roitman; P D Harvey; C S Blum; R L DuPre; D M Prieto; M Davidson; K L Davis
Journal:  Schizophr Res       Date:  1995-09       Impact factor: 4.939

Review 10.  Prefrontal activation deficits during episodic memory in schizophrenia.

Authors:  John D Ragland; Angela R Laird; Charan Ranganath; Robert S Blumenfeld; Sabina M Gonzales; David C Glahn
Journal:  Am J Psychiatry       Date:  2009-05-01       Impact factor: 18.112

View more
  186 in total

Review 1.  Cognition in schizophrenia: core psychological and neural mechanisms.

Authors:  Deanna M Barch; Alan Ceaser
Journal:  Trends Cogn Sci       Date:  2011-12-12       Impact factor: 20.229

2.  Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features.

Authors:  Allison A Curley; Dominique Arion; David W Volk; Josephine K Asafu-Adjei; Allan R Sampson; Kenneth N Fish; David A Lewis
Journal:  Am J Psychiatry       Date:  2011-06-01       Impact factor: 18.112

3.  General and specific functional connectivity disturbances in first-episode schizophrenia during cognitive control performance.

Authors:  Alex Fornito; Jong Yoon; Andrew Zalesky; Edward T Bullmore; Cameron S Carter
Journal:  Biol Psychiatry       Date:  2011-04-22       Impact factor: 13.382

Review 4.  NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia.

Authors:  Guillermo Gonzalez-Burgos; David A Lewis
Journal:  Schizophr Bull       Date:  2012-02-21       Impact factor: 9.306

Review 5.  From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.

Authors:  Bita Moghaddam; Daniel Javitt
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

6.  Effects of ZNF804A on neurophysiologic measures of cognitive control.

Authors:  K Thurin; R Rasetti; F Sambataro; M Safrin; Q Chen; J H Callicott; V S Mattay; D R Weinberger
Journal:  Mol Psychiatry       Date:  2012-10-02       Impact factor: 15.992

7.  Costs and benefits linked to developments in cognitive control.

Authors:  Katharine A Blackwell; Yuko Munakata
Journal:  Dev Sci       Date:  2013-12-14

8.  Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects.

Authors:  J R Glausier; K N Fish; D A Lewis
Journal:  Mol Psychiatry       Date:  2013-11-12       Impact factor: 15.992

9.  Emotion regulation abnormalities in schizophrenia: Directed attention strategies fail to decrease the neurophysiological response to unpleasant stimuli.

Authors:  Gregory P Strauss; Emily S Kappenman; Adam J Culbreth; Lauren T Catalano; Kathryn L Ossenfort; Bern G Lee; James M Gold
Journal:  J Abnorm Psychol       Date:  2014-12-08

10.  Altered Expression of ARP2/3 Complex Signaling Pathway Genes in Prefrontal Layer 3 Pyramidal Cells in Schizophrenia.

Authors:  Dibyadeep Datta; Dominique Arion; Kaitlyn M Roman; David W Volk; David A Lewis
Journal:  Am J Psychiatry       Date:  2016-08-13       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.